The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp412
MANAGEMENT OF GASTROINTESTINAL COMPLICATIONS OF IMMUNOTHERAPY
Date
May 19, 2024
Explore related products in the following collection:
Background: Immune checkpoint inhibitors (ICIs) are used to treat several malignancies but predispose to systemic autoimmune inflammation referred to as immune-related adverse events (irAE). Upper and lower gastrointestinal (GI) tract inflammation are commonly encountered toxicities…